Evoke Pharma Inc (NASDAQ:EVOK) Stock Sees Bullish Momentum After The News

August 16, 2021

Evoke Pharma Inc (NASDAQ:EVOK) jumped 20% after announcing its Q2 2021 financial results for the period ended June 30, 2021, including the latest corporate developments.CEO David Gonyer said that through the company’s ongoing commercial expansion, growing visibility in the gastroparesis community, and enhanced in-person physician access, they are motivated by the progress made in Q2 2021. He added that the company continued to witness promising trends in refills, prescribing physicians,…

Read More >>

Evoke Pharma Inc. (NASDAQ: EVOK) Launches Physician and Patient Experience Program for GIMOTI

July 15, 2021

Evoke Pharma Inc. (NASDAQ: EVOK) dropped 3.17% after the company announced the commencement of more marketing initiatives focusing on introducing physician and patient experience programs for GIMOTI, its nasal spray of relief of acute and recurrent diabetic gastroparesis (DGP) symptoms.  Evoke launches GIMOTI experience program  The program will offer GIMOTI samples mainly to advance practice practitioners and targeted gastroenterologists. Most importantly, the program will expand GIMOTI awareness and trials for…

Read More >>